220 related articles for article (PubMed ID: 28301655)
1. Evaluation of singlet oxygen explicit dosimetry for predicting treatment outcomes of benzoporphyrin derivative monoacid ring A-mediated photodynamic therapy.
Kim MM; Penjweini R; Zhu TC
J Biomed Opt; 2017 Feb; 22(2):28002. PubMed ID: 28301655
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species explicit dosimetry to predict tumor growth for benzoporphyrin derivative-mediated vascular photodynamic therapy.
Sheng T; Ong YH; Guo W; Zhu T
J Biomed Opt; 2020 Jan; 25(6):1-13. PubMed ID: 31912689
[TBL] [Abstract][Full Text] [Related]
3. Explicit macroscopic singlet oxygen modeling for benzoporphyrin derivative monoacid ring A (BPD)-mediated photodynamic therapy.
Kim MM; Penjweini R; Liang X; Zhu TC
J Photochem Photobiol B; 2016 Nov; 164():314-322. PubMed ID: 27721165
[TBL] [Abstract][Full Text] [Related]
4. Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.
Weston MA; Patterson MS
Photochem Photobiol; 2011; 87(5):1129-37. PubMed ID: 21575000
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling.
Penjweini R; Kim MM; Liu B; Zhu TC
J Biophotonics; 2016 Dec; 9(11-12):1344-1354. PubMed ID: 27653233
[TBL] [Abstract][Full Text] [Related]
6. Macroscopic singlet oxygen modeling for dosimetry of Photofrin-mediated photodynamic therapy: an in-vivo study.
Qiu H; Kim MM; Penjweini R; Zhu TC
J Biomed Opt; 2016 Aug; 21(8):88002. PubMed ID: 27552311
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.
Qiu H; Kim MM; Penjweini R; Finlay JC; Busch TM; Wang T; Guo W; Cengel KA; Simone CB; Glatstein E; Zhu TC
Photochem Photobiol; 2017 Jul; 93(4):1115-1122. PubMed ID: 28083883
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity.
Pogue BW; O'Hara JA; Demidenko E; Wilmot CM; Goodwin IA; Chen B; Swartz HM; Hasan T
Cancer Res; 2003 Mar; 63(5):1025-33. PubMed ID: 12615718
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species explicit dosimetry to predict tumor growth for BPD-mediated vascular photodynamic therapy.
Sheng T; Ong YH; Busch TM; Zhu TC
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10861():. PubMed ID: 31080306
[TBL] [Abstract][Full Text] [Related]
10.
Penjweini R; Kim MM; Ong YH; Zhu TC
Phys Med Biol; 2020 Jan; 65(3):03LT01. PubMed ID: 31751964
[TBL] [Abstract][Full Text] [Related]
11. Explicit dosimetry for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a-mediated photodynamic therapy: macroscopic singlet oxygen modeling.
Penjweini R; Liu B; Kim MM; Zhu TC
J Biomed Opt; 2015; 20(12):128003. PubMed ID: 26720883
[TBL] [Abstract][Full Text] [Related]
12. Macroscopic singlet oxygen model incorporating photobleaching as an input parameter.
Kim MM; Finlay JC; Zhu TC
Proc SPIE Int Soc Opt Eng; 2015 Mar; 9308():93080V. PubMed ID: 25914795
[TBL] [Abstract][Full Text] [Related]
13. Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer.
James NS; Cheruku RR; Missert JR; Sunar U; Pandey RK
Molecules; 2018 Jul; 23(8):. PubMed ID: 30042350
[TBL] [Abstract][Full Text] [Related]
14. Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling.
Wang KK; Finlay JC; Busch TM; Hahn SM; Zhu TC
J Biophotonics; 2010 Jun; 3(5-6):304-18. PubMed ID: 20222102
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species explicit dosimetry to predict local tumor control for Photofrin-mediated photodynamic therapy.
Sheng T; Ong YH; Busch TM; Zhu TC
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10860():. PubMed ID: 31327886
[TBL] [Abstract][Full Text] [Related]
16.
Kim MM; Penjweini R; Zhu TC
Proc SPIE Int Soc Opt Eng; 2015 Mar; 9308():. PubMed ID: 25999655
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative.
Simkin GO; King DE; Levy JG; Chan AH; Hunt DW
Immunopharmacology; 1997 Oct; 37(2-3):221-30. PubMed ID: 9403341
[TBL] [Abstract][Full Text] [Related]
18. Validation of combined Monte Carlo and photokinetic simulations for the outcome correlation analysis of benzoporphyrin derivative-mediated photodynamic therapy on mice.
Beeson KW; Parilov E; Potasek M; Kim MM; Zhu TC
J Biomed Opt; 2019 Mar; 24(3):1-9. PubMed ID: 30873764
[TBL] [Abstract][Full Text] [Related]
19. Dosimetry study of PHOTOFRIN-mediated photodynamic therapy in a mouse tumor model.
Qiu H; Kim MM; Penjweini R; Zhu TC
Proc SPIE Int Soc Opt Eng; 2016 Feb; 9694():. PubMed ID: 27053822
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species explicit dosimetry to predict local tumor growth for Photofrin-mediated photodynamic therapy.
Sheng T; Ong Y; Busch TM; Zhu TC
Biomed Opt Express; 2020 Aug; 11(8):4586-4601. PubMed ID: 32923066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
